Senior Editor, Diagnostic Imaging
In the second part of a recent interview, Chris Mattern. M.D., discussed the increasing burden of non-clinical tasks upon radiologist workloads and the potential of the emerging enterprise imaging platform MosaicOS to address efficiency and restore the focus on clinical care.
Incorporating technology from Siemens Healthineers’ Magnetom Skyra Fit system, the Invision 3T Recharge Operating Suite offers AI-powrred protocols and automated image reconstruction capabilities.
Could the NeedleVue LC1 Ultrasound System reinvent real-time ultrasound-assisted needle guidance for interventional procedures?
In the second of a two-part podcast episode, Jeremie Calais, M.D., and Robert Flavell, M.D., discuss current and emerging alpha-emitting therapies, possible roles for artificial intelligence (AI), and what the future may hold for theranostic applications in patients with prostate cancer.
Emphasizing advanced orchestration of imaging workflows, the Rhapsody Image Director software reportedly facilitates streamlined efficiency and infrastructure that accommodates multimodal AI tools.
Patient with biochemical recurrence of prostate cancer who had PSMA PET/CT prior to salvage radiotherapy had better survival rates at one, two and five years, according to newly published research.
Researchers noted a 78 percent malignancy rate when associated architectural distortion was present on digital breast tomosynthesis (DBT) with highly suspicious masses or microcalcifications.
The iPETcertum software reportedly provides automated segmentation and enhanced visualization of regions of interest on PET scans with a single click.
In a recent interview, Tammie Benzinger, M.D., Ph.D., discussed the utility of portable low-field MRI to help identify patients in remote settings who may be viable candidates for subsequent MRI workup and consideration for new anti-amyloid therapies in treating Alzheimer’s disease.
In comparison to computed tomography and bone scintigraphy, FDG PET/CT detected more oligometastatic and polymetastatic disease in patients with locally advanced breast cancer, according to a new study.
A deep learning multimodal model that incorporates MRI features offered nearly double the sensitivity for predicting post-prostatectomy biochemical recurrence of prostate cancer in comparison to the traditional CAPRA-S scoring system.
In the first of a two-part podcast episode, Jeremie Calais, M.D., and Robert Flavell, M.D., discuss recent advances with PSMA-targeted radiotracers in the treatment of metastatic castration-resistant prostate cancer (mCRPC), and the role of imaging criteria in monitoring patients treated with PSMA-targeted radionuclide therapy.
In addition to facilitating centralized scanning for a variety of imaging, the TechLive system may help ease the strain of technologist shortages and broaden access to advanced imaging exams.
In a recent interview, Chris Mattern, M.D., discussed a confluence of trends that may be contributing to burnout in radiology, early retirements and a shifting preference from full-time to part-time roles in radiology.
Lower proportions of extremely dense breasts and high BRCAT lifetime risk among Black women in comparison to White women may have resulted in a lower likelihood of eligibility for supplemental screening insurance coverage in Pennsylvania, according to new research.
While a CT-based deep learning model demonstrated a 91 percent AUC for predicting lung cancer risk within one year, researchers noted other mixed results in a new study involving over 18,000 individuals.
Combining sub-second load times and AI-automated features, the PET/CT Viewer Mode and Mammography Viewer Mode may help address bottlenecks in nuclear medicine imaging and mammography workflows.
Offering an 87 percent sensitivity for clinically significant prostate cancer (csPCa), the deep learning model demonstrated an 86 percent AUC for predicting > PI-RADS 3 lesions on prostate MRI.
In a recent interview, Amy Patel, M.D., discussed new research findings that revealed a 45 percent higher likelihood of mammography screening among women with Medicaid in Missouri due to expanded mammography coverage in the state.
The multimodality remote scanning modality uOmniscan and the recently FDA-cleared 3T uMR Ultra MRI system were unveiled at the Association for Medical Imaging Management (AHRA) conference in Las Vegas.
In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
Mammography detected 82 percent of pregnancy-associated breast cancer in a cohort of women with a high prevalence of extremely dense breasts, according to a new study.
In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
In a recent interview, Jamie Williams, M.D., discussed newly published research findings revealing the impact of high-resolution digital breast tomosynthesis (DBT) on breast cancer detection and recall rates.
The addition of two new AI-enabled models for the latest version of the NeuroQuant Brain Tumor software facilitates automated tracking of the progression of brain tumors and meningiomas.
In a retrospective review of screening digital breast tomosynthesis (DBT) exams for over 200 women with interval breast cancers, researchers found that AI provided accurate localization of cancers in 32.6 percent of the cases.
Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
In a recent interview, Matt Covington, M.D., discussed challenges with the development of radioligand therapies for breast cancer and the potential of emerging radioligand agents to augment current treatment options in this patient population.
In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
